GOSY yields 2000000.00% · PFE yields 6.13%● Live data
📍 GOSY pulled ahead of the other in Year 1
Combined, GOSY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GOSY + PFE for your $10,000?
GeckoSystems International Corporation engages in the development and supply of mobile robot solutions for safety, security, and service to the consumer, business, and government markets. It offers mobile service robots (MSRs) that automatically self-navigate homes or workplace. The company's products comprise GeckoNav, an automatic navigation control system based on fuzzy hybrid architecture; GeckoSuper that acts as the central hub through which GeckoSavants communicate with each other; GeckoScheduler that enables mobile robots to timely and repetitively remind the care receiver of various events; GeckoChat, a conversational artificial intelligence system that allows the user to verbally interact with those GSI systems, which have GeckoChat bilateral communication capability; and GeckoTrak, which merges and interprets data from sensor systems to achieve sensor fusion to automatically follow a designated person anywhere in the home. Its products also include GeckoSPIO, a robot controller circuit board that contains passive and active components; GeckoImager, which allows the system to process approximately 2,000 times more raw data than the CompoundedSensorArray system; GeckoOrient, which merges sensor data from odometry for enhanced orientation accuracy while errand running, patrolling, or following a designated person; GeckoSteer, a solution to address issues unique to the collision proof wheelchair; and GeckoMotorController that uses feedback from optical encoders to control wheel velocity. In addition, the company provides GeckoZap, a test, calibrate, and debug software suite; and CareBot MSR technology. GeckoSystems Intl. Corp. was founded in 1997 and is based in Conyers, Georgia.
Full GOSY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.